NCT07217769

Brief Summary

Night shift work schedules disrupt sleep and have a negative impact on cardiovascular health. Most who work in public safety occupations and in healthcare work night shifts. These workers experience abnormal blood pressure during night shifts and are at greater risk of cardiovascular disease. Napping during night shifts can help to restore blood pressure patterns to a more normal pattern and may help to reduce risk of cardiovascular disease. Naps may also have an impact on alertness and performance immediately upon waking. The overarching goal of this study is to determine which duration of a nap taken during simulated night shift work has the greatest impact blood pressure and post-nap performance. Researchers will compare 5 nap durations to see which has the greatest impact on blood pressure patterns and post-nap psychomotor performance. Researchers hypothesize that longer naps will lead to improved blood pressure outcomes and shorter naps will contribute to better performance after waking. Findings will help employers and employees who work night shifts determine how best to incorporate brief naps during night shift work.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
130

participants targeted

Target at P50-P75 for not_applicable

Timeline
53mo left

Started May 2026

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 2, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

October 16, 2025

Completed
7 months until next milestone

Study Start

First participant enrolled

May 1, 2026

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2030

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2030

Last Updated

April 30, 2026

Status Verified

April 1, 2026

Enrollment Period

4.3 years

First QC Date

October 2, 2025

Last Update Submit

April 29, 2026

Conditions

Keywords

Night shiftSleepNappingBlood pressurePsychomotor performanceSleep inertiaCaffeine

Outcome Measures

Primary Outcomes (2)

  • BP dipping

    The ratio of mean sleep to mean wake blood pressure (BP) by taking the difference between the mean systolic blood pressure (SBP) and diastolic blood pressure (DBP) during nap opportunities, and the mean SBP and DBP during wake periods.

    During simulated night shift, 12 hours

  • Psychomotor performance post-nap

    Severe psychomotor impairment post-nap as measured by the Psychomotor Vigilance Test Brief (PVT-B)

    During simulated night shift, greater than or equal to 10 minutes post intervention nap

Secondary Outcomes (1)

  • Performance on simulated patient scenarios

    During simulated night shift, 12 hours

Study Arms (1)

Napping order

OTHER

5 x 4 x 3 x 2 = 120 possible orderings of the 5 interventions for each person.

Behavioral: No-napBehavioral: 15-min napBehavioral: 30-min napBehavioral: 45-min napBehavioral: 60-min nap

Interventions

No-napBEHAVIORAL

No-nap opportunity offered

Napping order
15-min napBEHAVIORAL

A 15-minute nap opportunity at 02:00am

Napping order
30-min napBEHAVIORAL

A 30-minute nap opportunity at 02:00am

Napping order
45-min napBEHAVIORAL

A 45-minute nap opportunity at 02:00am

Napping order
60-min napBEHAVIORAL

A 60-minute nap opportunity at 02:00am

Napping order

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • non-pregnant adults (\>18 years of age)
  • certified public safety/healthcare shift worker
  • is an active shift worker
  • resides within the Western Pennsylvania region within reasonable driving distance

You may not qualify if:

  • current use of medication for cardiovascular disease (e.g., hypertension)
  • prior or current diagnosis of sleep apnea, narcolepsy, restless leg syndrome, ischemic heart disease, heart failure, stroke, chronic kidney disease, chronic liver disease, rheumatologic disease requiring prescription medication, and cancer requiring treatment in past 2 years
  • undiagnosed severe sleep apnea (Apnea-Hypopnea Index \>30) based on at-home test
  • Abstains from caffeine or reports adverse effects from caffeine use

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15261, United States

RECRUITING

MeSH Terms

Conditions

Idiopathic Hypersomnia

Condition Hierarchy (Ancestors)

Disorders of Excessive SomnolenceSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Daniel Patterson

    University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Daniel Patterson, PhD

CONTACT

Maureen Morgan

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Participants are blinded to the nap duration.
Purpose
OTHER
Intervention Model
CROSSOVER
Model Details: This study uses an incomplete block design with participants completing 4 of the 5 conditions in random order.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

October 2, 2025

First Posted

October 16, 2025

Study Start

May 1, 2026

Primary Completion (Estimated)

August 31, 2030

Study Completion (Estimated)

August 31, 2030

Last Updated

April 30, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

All collected IPD

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
No later than 3 years after completing the last follow-up of the last participant.
Access Criteria
Access through NHLBI BioLINCC repository

Locations